ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01705990
Recruitment Status : Completed
First Posted : October 15, 2012
Last Update Posted : August 26, 2015
Sponsor:
Information provided by (Responsible Party):
International AIDS Vaccine Initiative